Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling

Journal of Immunology

Volumn 193, Issue 8, 2014, Pages 4149-4158

  Wang, Yu Chih ^a,b   Chen, Chia Ling ^c   Sheu, Bor Shyang ^a   Yang, Yao Jong ^a   Tseng, Po Chun ^a   Hsieh, Chia Yuan ^a   Lin, Chiou Feng ^a,b,d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; IRF1 PROTEIN, HUMAN; PTPN11 PROTEIN, HUMAN; SMALL INTERFERING RNA; STAT1 PROTEIN, HUMAN;

ARTICLE; AZ 521 CELL LINE; BACTERIAL VIABILITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INTESTINE CELL; MEMBRANE BINDING; MKN45 CELL LINE; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; U937 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARCINOGENESIS; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; MOUSE; PHOSPHORYLATION; RNA INTERFERENCE; STOMACH MUCOSA; TUMOR CELL LINE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARCINOGENESIS; CELL LINE, TUMOR; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; U937 CELLS;

EID: 84907525430     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400594     Document Type: Article

References (67)

1. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96: 41-101.
2. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
3. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
4. Song, M. M., and K. Shuai. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273: 35056-35062.
5. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465.
6. Wu, T. R., Y. K. Hong, X. D. Wang, M. Y. Ling, A. M. Dragoi, A. S. Chung, A. G. Campbell, Z. Y. Han, G. S. Feng, and Y. E. Chin. 2002. SHP-2 is a dualspecificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J. Biol. Chem. 277: 47572-47580.
7. You, M., D. H. Yu, and G. S. Feng. 1999. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol. Cell. Biol. 19: 2416-2424.
8. Neel, B. G., H. Gu, and L. Pao. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28: 284-293.
9. Najjar, I., and R. Fagard. 2010. STAT1 and pathogens, not a friendly relationship. Biochimie 92: 425-444.
10. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8: 907-922.
11. Algood, H. M., and T. L. Cover. 2006. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev. 19: 597-613.
12. Peek, R. M., Jr., C. Fiske, and K. T. Wilson. 2010. Role of innate immunity inHelicobacter pylori-induced gastric malignancy. Physiol. Rev. 90: 831-858.
13. Polk, D. B., and R. M. Peek, Jr. 2010. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10: 403-414.
14. Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori Cag. Protein Sci. 295: 683-686.
15. Hatakeyama, M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4: 688-694.
16. Matozaki, T., Y. Murata, Y. Saito, H. Okazawa, and H. Ohnishi. 2009. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci. 100: 1786-1793.
17. Ohnishi, N., H. Yuasa, S. Tanaka, H. Sawa, M. Miura, A. Matsui, H. Higashi, M. Musashi, K. Iwabuchi, M. Suzuki, et al. 2008. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA 105: 1003-1008.
18. Kusters, J. G., A. H. van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19: 449-490.
19. Serrano, C., M. I. Diaz, A. Valdivia, A. Godoy, A. Peña, A. Rollan, A. Kirberg, E. Hebel, J. Fierro, G. Klapp, et al. 2007. Relationship between Helicobacter pylori virulence factors and regulatory cytokines as predictors of clinical outcome. Microbes Infect. 9: 428-434.
20. Straubinger, R. K., A. Greiter, S. P. McDonough, A. Gerold, E. Scanziani, S. Soldati, D. Dailidiene, G. Dailide, D. E. Berg, and K. W. Simpson. 2003. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect. Immun. 71: 2693-2703.
21. Meyer, F., K. T. Wilson, and S. P. James. 2000. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun. 68: 6265-6272.
22. Akhiani, A. A., J. Pappo, Z. Kabok, K. Schön, W. Gao, L. E. Franzén, and N. Lycke. 2002. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol. 169: 6977-6984.
23. Eaton, K. A., L. H. Benson, J. Haeger, and B. M. Gray. 2006. Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice. Infect. Immun. 74: 4673-4684.
24. Sawai, N., M. Kita, T. Kodama, T. Tanahashi, Y. Yamaoka, Y. Tagawa, Y. Iwakura, and J. Imanishi. 1999. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 67: 279-285.
25. Sommer, F., G. Faller, M. Röllinghoff, T. Kirchner, T. W. Mak, and M. Lohoff. 2001. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori. Eur. J. Immunol. 31: 396-402.
26. Yamamoto, T., M. Kita, T. Ohno, Y. Iwakura, K. Sekikawa, and J. Imanishi. 2004. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol. Immunol. 48: 647-654.
27. Thye, T., G. D. Burchard, M. Nilius, B. Müller-Myhsok, and R. D. Horstmann. 2003. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am. J. Hum. Genet. 72: 448-453.
28. Zhao, Y., Y. Zhou, Y. Sun, A. Yu, H. Yu, W. Li, Z. Liu, J. Zeng, X. Li, C. Chen, and J. Jia. 2011. Virulence factor cytotoxin-associated gene A in Helicobacter pylori is downregulated by interferon-g in vitro. FEMS Immunol. Med. Microbiol. 61: 76-83.
29. Tu, S. P., M. Quante, G. Bhagat, S. Takaishi, G. Cui, X. D. Yang, S. Muthuplani, W. Shibata, J. G. Fox, D. M. Pritchard, and T. C. Wang. 2011. IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res. 71: 4247-4259.
30. Mitchell, D. J., H. Q. Huynh, P. J. Ceponis, N. L. Jones, and P. M. Sherman. 2004. Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect. Immun. 72: 537-545.
31. Wang, Y. H., J. J. Wu, and H. Y. Lei. 2009. The autophagic induction in Helicobacter pylori-infected macrophage. Exp. Biol. Med. (Maywood) 234: 171-180.
32. Yang, Y. J., C. C. Chuang, H. B. Yang, C. C. Lu, and B. S. Sheu. 2012. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFkB pathways. BMC Microbiol. 12: 38.
33. Chuang, C. H., H. B. Yang, S. M. Sheu, K. H. Hung, J. J. Wu, H. C. Cheng, W. L. Chang, and B. S. Sheu. 2011. Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer. BMC Microbiol. 11: 121.
34. Nagy, T. A., M. R. Frey, F. Yan, D. A. Israel, D. B. Polk, and R. M. Peek, Jr. 2009. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J. Infect. Dis. 199: 641-651.
35. Bernhardt, A., D. Kuester, A. Roessner, T. Reinheckel, and S. Krueger. 2010. Cathepsin X-deficient gastric epithelial cells in co-culture with macrophages: characterization of cytokine response and migration capability after Helicobacter pylori infection. J. Biol. Chem. 285: 33691-33700.
36. Tsai, C. C., J. I. Kai, W. C. Huang, C. Y. Wang, Y. Wang, C. L. Chen, Y. T. Fang, Y. S. Lin, R. Anderson, S. H. Chen, et al. 2009. Glycogen synthase kinase-3betafacilitates IFN-gamma;-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J. Immunol. 183: 856-864.
37. Tseng, P. C., W. C. Huang, C. L. Chen, B. S. Sheu, Y. S. Shan, C. C. Tsai, C. Y. Wang, S. O. Chen, C. Y. Hsieh, and C. F. Lin. 2012. Regulation of SHP2 by PTEN/AKT/GSK-3b signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer. Immunobiology 217: 926-934.
38. Kovarik, P., D. Stoiber, P. A. Eyers, R. Menghini, A. Neininger, M. Gaestel, P. Cohen, and T. Decker. 1999. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma; uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 96: 13956-13961.
39. Park, S. J., H. Y. Kim, H. Kim, S. M. Park, E. H. Joe, I. Jou, and Y. H. Choi. 2009. Oxidative stress induces lipid-raft-mediated activation of Src homology 2 domain-containing protein-tyrosine phosphatase 2 in astrocytes. Free Radic. Biol. Med. 46: 1694-1702.
40. Yun, J. H., S. J. Park, A. Jo, J. L. Kang, I. Jou, J. S. Park, and Y. H. Choi. 2011. Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes. Exp. Mol. Med. 43: 660-668.
41. Cha, B., J. W. Lim, K. H. Kim, and H. Kim. 2010. HSP90beta interacts withRac1 to activate NADPH oxidase in Helicobacter pylori-infected gastric epithelial cells. Int. J. Biochem. Cell Biol. 42: 1455-1461.
42. Backert, S., and M. Clyne. 2011. Pathogenesis of Helicobacter pylori infection. Helicobacter 16(Suppl 1): 19-25.
43. Costa, A. C., C. Figueiredo, and E. Touati. 2009. Pathogenesis of Helicobacter pylori infection. Helicobacter 14(Suppl 1): 15-20.
44. Delahay, R. M., and M. Rugge. 2012. Pathogenesis of Helicobacter pylori infection. Helicobacter 17(Suppl 1): 9-15.
45. Maeda, S., and A. F. Mentis. 2007. Pathogenesis of Helicobacter pylori infection. Helicobacter 12(Suppl 1): 10-14.
46. Radosz-Komoniewska, H., T. Bek, J. Jóźwiak, and G. Martirosian. 2005. Pathogenicity of Helicobacter pylori infection. Clin. Microbiol. Infect. 11: 602-610.
47. Torres, J., and S. Backert. 2008. Pathogenesis of Helicobacter pylori infection. Helicobacter 13(Suppl 1): 13-17.
48. Sayi, A., E. Kohler, I. Hitzler, I. Arnold, R. Schwendener, H. Rehrauer, and A. Müller. 2009. The CD4+ T cell-mediated IFN-gamma; response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J. Immunol. 182: 7085-7101.
49. Menaker, R. J., P. J. Ceponis, and N. L. Jones. 2004. Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect. Immun. 72: 2889-2898.
50. Baron, M., and J. L. Davignon. 2008. Inhibition of IFN-gamma;-induced STAT1 tyrosine phosphorylation by human CMVis mediated by SHP2. J. Immunol. 181: 5530-5536.
51. Blanchette, J., N. Racette, R. Faure, K. A. Siminovitch, and M. Olivier. 1999. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma;-triggered JAK2 activation. Eur. J. Immunol. 29: 3737-3744.
52. Kraft, M., S. Riedel, C. Maaser, T. Kucharzik, A. Steinbuechel, W. Domschke, and N. Luegering. 2001. IFN-gamma; synergizes with TNF-αlpha but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells. Clin. Exp. Immunol. 126: 474-481.
53. Allison, C. C., J. Ferrand, L. McLeod, M. Hassan, M. Kaparakis-Liaskos, A. Grubman, P. S. Bhathal, A. Dev, W. Sievert, B. J. Jenkins, and R. L. Ferrero. 2013. Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity. J. Immunol. 190: 3706-3715.
54. Smyth, D., C. M. McKay, B. D. Gulbransen, V. C. Phan, A. Wang, and D. M. McKay. 2012. Interferon-gamma signals via an ERK1/2-ARF6 pathway to promote bacterial internalization by gut epithelia. Cell. Microbiol. 14: 1257-1270.
55. Won, K. J., H. M. Lee, C. K. Lee, H. Y. Lin, H. Na, K. W. Lim, H. Y. Roh, S. Sim, H. Song, W. S. Choi, et al. 2011. Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway. J. Pharmacol. Sci. 115: 164-175.
56. Lucero, H. A., K. Ravid, J. L. Grimsby, C. B. Rich, S. J. DiCamillo, J. M. Mäki, J. Myllyharju, and H. M. Kagan. 2008. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J. Biol. Chem. 283: 24103-24117.
57. Teshima, S., S. Tsunawaki, and K. Rokutan. 1999. Helicobacter pylori lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells. FEBS Lett. 452: 243-246.
58. Tsugawa, H., H. Suzuki, H. Saya, M. Hatakeyama, T. Hirayama, K. Hirata, O. Nagano, J. Matsuzaki, and T. Hibi. 2012. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 12: 764-777.
59. Handa, O., Y. Naito, and T. Yoshikawa. 2010. Helicobacter pylori: a ROSinducing bacterial species in the stomach. Inflamm. Res. 59: 997-1003.
60. Naito, Y., and T. Yoshikawa. 2002. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 33: 323-336.
61. Samayawardhena, L. A., J. Hu, P. L. Stein, and A. W. Craig. 2006. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell. Signal. 18: 1447-1454.
62. Charest, A., E. W. Wilker, M. E. McLaughlin, K. Lane, R. Gowda, S. Coven, K. McMahon, S. Kovach, Y. Feng, M. B. Yaffe, et al. 2006. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res. 66: 7473-7481.
63. Kwon, J., C. K. Qu, J. S. Maeng, R. Falahati, C. Lee, and M. S. Williams. 2005. Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP- 76-ADAP. EMBO J. 24: 2331-2341.
64. Meng, T. C., T. Fukada, and N. K. Tonks. 2002. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9: 387-399.
65. Wang, H., J. Brown, and M. Martin. 2011. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 53: 130-140.
66. Nakayama, M., J. Hisatsune, E. Yamasaki, H. Isomoto, H. Kurazono, M. Hatakeyama, T. Azuma, Y. Yamaoka, K. Yahiro, J. Moss, and T. Hirayama. 2009. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/ Akt signaling pathway. J. Biol. Chem. 284: 1612-1619.
67. Tabassam, F. H., D. Y. Graham, and Y. Yamaoka. 2009. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell. Microbiol. 11: 70-82.